![](/img/cover-not-exists.png)
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
Gatell, José M., Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans–Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, MarVolume:
31
Language:
english
Journal:
AIDS
DOI:
10.1097/QAD.0000000000001675
Date:
November, 2017
File:
PDF, 744 KB
english, 2017